Curve Therapeutics

Drug Discovery, Differently.

Southampton, United Kingdom · Founded 2019 · $51.4M raised

Headquarters
Southampton
Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$51.4M
Last Round
$51.4M Series AFeb 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Curve Therapeutics is a private UK biotechnology company using its proprietary mammalian cell-based Microcycle® discovery platform to discover novel cyclic peptide and small molecule drugs targeting intracellular disease targets. Founded as a University of Southampton spinout, the company focuses on cancer, immunology, and inflammation, with a pipeline of macrocycle-derived drugs that address targets conventional methods cannot reach. Its Microcycles are compact, rigid macrocycles that behave like small molecules, enabling functional screening inside living mammalian cells. The company raised a £40.5 million ($51M) Series A led by Pfizer Ventures in 2024.

Summary

Curve Therapeutics is a Biotech company based in Southampton, United Kingdom, founded in 2019. It has raised $51.4M in total across 1 round, most recently a $51.4M Series A round in Feb 2024. Investors include Pfizer Ventures, Columbus Venture Partners and Advent Life Sciences.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AFeb 2024
$51.4M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Curve Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/curve-therapeutics"><img src="https://indexed.vc/api/badge/company/curve-therapeutics" alt="Curve Therapeutics on Indexed.vc" width="260" height="76" /></a>